| Report Name | Report Type | Specialty | Publish Date | |
|---|---|---|---|---|
| ADHD: Evaluation of Current and Emerging Therapies (Wave 2) | Survey | Pediatrics, Psychiatry | Jan 28, 2008 | PAID REPORT |
| To understand the use of ADHD medications (specifically Vyvnase and generic Adderall) Quantify current treatment practices in child, adolescent, and patient populations Understand the future use of Vyvnase and generic Adderall under different... | ||||
| ADHD: Evaluation of Current and Emerging Therapies | Survey | Pediatrics, Psychiatry | Mar 18, 2007 | FREE |
| To evaluate current use of ADHD medications as well as the potential impact of entry of Vyvanse� and generic Adderall XR � to this market. Quantify current treatment practices in child, adolescent and adult patient populations Assess level of concern over... | ||||
| Trends in RSV Prophylaxis | Discussion | Pediatrics | Dec 12, 2006 | FREE |
| n Assess the level of awareness and anticipation for MedImmune/AstraZeneca�s Numax� and its potential use in the prevention of respiratory syncytial virus (RSV) n Elicit expert feedback on Numax n Determine potential to displace... | ||||
| Synagis Market Analysis | Survey | Pediatrics | Nov 13, 2006 | FREE |
| Determine previous changes within the Synagis market and predict the future market of the drug Examine background information on how pediatricians and pediatric specialists have used Synagis in the past Determine the current use of Synagis compared to previous seasons Predict the... | ||||
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |